Vui lòng dùng định danh này để trích dẫn hoặc liên kết đến tài liệu này: http://thuvienso.vanlanguni.edu.vn/handle/Vanlang_TV/15139
Toàn bộ biểu ghi siêu dữ liệu
Trường DCGiá trị Ngôn ngữ
dc.contributor.authorMadit, Nicolas-
dc.contributor.authorRichardson, Matt-
dc.date.accessioned2020-02-11T07:34:15Z-
dc.date.available2020-02-11T07:34:15Z-
dc.date.issued2019-
dc.identifier.issn1543-2521-
dc.identifier.issn2150-7376 (e)-
dc.identifier.otherBBKH692-
dc.identifier.urihttp://thuvienso.vanlanguni.edu.vn/handle/Vanlang_TV/15139-
dc.descriptionPharmaceutical Technology APIs, Excipients, and manufacturing 2019vi
dc.description.abstractGelatine relies on water for plasticity, while HPMC capsules do not. [...]HPMC capsules can sustain mechanical stability at a lower percent relative humidity (% RH) range (Figure 1) and are better suited for moisture-sensitive and hygroscopic APIs (1). HPMC shells demonstrated less hydrolysis caused from the moisture content contained in the capsule shells, meaning increased shelf life of moisture-sensitive compounds encapsulated in HPMC capsules and continued safety and efficacy of the drug. A human bioequivalence study of Vcaps Plus (Lonza Capsugel) capsules, with 24 patients, demonstrated equivalent performance to hard gelatin capsules with three BDCCS Class 1 biomarkers-acetaminophen, acetylsalicylic acid, and caffeine-further demonstrating its excellent performance while similar studies done on HPMC capsules which do contain a gelling system show greater intra-patient variability as well as a notable difference in onset time of drug absorption (Tlag) (4). Conclusion With the ability to protect encapsulated APIs against moisture, HPMC capsules are an ideal formulation tool when gelatine capsules are incompatible. [...]HPMC capsules without gelling systems have been designed to overcome inconsistent dissolution performance presented by the interaction between gelling agents and the dissolution environment.vi
dc.language.isoenvi
dc.publisherMultiMedia Healthcare Inc.vi
dc.subjectPolymersvi
dc.subjectPatient safetyvi
dc.subjectHumidityvi
dc.subjectManufacturingvi
dc.subjectManufacturersvi
dc.subjectPotassiumvi
dc.subjectCaffeinevi
dc.subjectPharmaceuticalsvi
dc.subjectRegulatory approvalvi
dc.subjectDrug dosagesvi
dc.titleAdvancements in Encapsulation Technologyvi
dc.typeWorking Papervi
Bộ sưu tập: Bài báo_lưu trữ

Các tập tin trong tài liệu này:
Tập tin Mô tả Kích thước Định dạng  
BBKH692_TCCN_Advancements in Encapsulation.pdf
  Giới hạn truy cập
Advancements in Encapsulation Technology1.68 MBAdobe PDFXem/Tải về  Yêu cầu tài liệu


Khi sử dụng các tài liệu trong Thư viện số phải tuân thủ Luật bản quyền.